Saúde Pública/Medicina Humanitária
Fauci afirma que versões de vacinas contra Covid-19 específicas para a variante Ômicron podem não ser necessárias.
13 Dez, 2021 | 11:39hFauci says Omicron-specific version of Covid-19 vaccines may not be necessary – STAT
Covid-19: vacinas funcionam contra a variante Ômicron? – Esta e outras questões respondidas.
13 Dez, 2021 | 11:38hCovid-19: Do vaccines work against omicron—and other questions answered – The BMJ
Opinião | Revogue-se a proibição de viagens partindo de países africanos.
13 Dez, 2021 | 11:36hRevoke the Omicron Travel Ban Against African Countries – The New York Times (alguns artigos gratuitos por mês)
Comentário no Twitter
Revoke the Omicron Travel Ban Against African Countries https://t.co/RhuHtnCYgR. Well said @SaadOmer3 this is not based in science and simply unjustifiable and needs to end now.
— Carlos del Rio (@CarlosdelRio7) December 11, 2021
Estudo de base populacional sobre câncer colorretal: incidência, mortalidade, características do tumor e tratamento antes e depois da introdução do programa de rastreamento baseado em testes imunoquímicos fecais na Holanda.
13 Dez, 2021 | 11:26hColorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study – The Lancet Gastroenterology & Hepatology (link para o resumo – $ para o texto completo)
Comentário no Twitter
New research – Breekveldt et al – #Colorectalcancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the FIT-based #screening programme in the #Netherlands: a population-based studyhttps://t.co/nW9SVAhRxE#GITwitter #crcsm pic.twitter.com/GGRF9Az0tg
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) November 23, 2021
Avanço das infecções por SARS-CoV-2 em indivíduos plenamente vacinados: medição, causas e impacto.
10 Dez, 2021 | 11:32h
Comentário no Twitter
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact https://t.co/dd91AkYmu4 pic.twitter.com/1ByzLeTdlh
— Nature Rev Immunol (@NatRevImmunol) December 7, 2021
Surgimento, diversidade genômica e disseminação global do SARS-CoV-2.
10 Dez, 2021 | 11:31hThe emergence, genomic diversity and global spread of SARS-CoV-2 – Nature
Editorial | Surgimento de variantes do SARS-CoV-2: atirando no mensageiro.
10 Dez, 2021 | 11:30hEmerging SARS-CoV-2 variants: shooting the messenger – The Lancet Infectious Diseases
Comentário no Twitter
"Omicron is the latest variant but is unlikely to be the last. We cannot risk disincentivising nations from alerting the world to new variants. In fact, globally, we would benefit from upscaling genomic surveillance" @TheLancetInfDis #IDTwitter #MedEd https://t.co/3Mz6WAgsKD
— Antibiotic Stewa®️x🆔 Bassam Ghanem (@ABsteward) December 9, 2021
Infodemia: um novo desafio para a saúde pública.
10 Dez, 2021 | 11:28hInfodemics: A new challenge for public health – Cell
Ver também:
What is an infodemic and how can we prevent it?
Comentário no Twitter
What pandemics and infodemics don’t have in common could help us learn how to fight them, experts suggest in a new @CellCellPress Commentary. Read more here: https://t.co/15nVCiebLI@Walter4C pic.twitter.com/7viNB9yRvR
— Cell Press (@CellPressNews) December 9, 2021
A variante Ômicron se dissemina, mas casos graves permanecem baixos na África do Sul.
10 Dez, 2021 | 11:27hOmicron spreads but severe cases remain low in South Africa – WHO Africa
Enquanto chegam dados preliminares da disseminação da variante Ômicron nos EUA, chefe do CDC sugere que a variante é “leve”.
10 Dez, 2021 | 11:26hCDC chief says Omicron is ‘mild’ as early data comes in on US spread of variant – The Guardian